Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 2
1987 2
1988 2
1989 8
1990 2
1991 3
1992 3
1994 4
1995 3
1996 4
1997 6
1998 6
1999 9
2000 2
2001 9
2002 5
2003 4
2004 9
2005 6
2006 2
2007 10
2008 17
2009 15
2010 19
2011 12
2012 12
2013 6
2014 7
2015 10
2016 13
2017 13
2018 7
2019 4
2020 5
2021 8
2022 7
2023 2
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239 results

Results by year

Filters applied: . Clear all
Page 1
Amyloid cerebrovasculopathies.
Scolding NJ. Scolding NJ. Pract Neurol. 2022 Jun;22(3):181-182. doi: 10.1136/practneurol-2022-003386. Epub 2022 Mar 21. Pract Neurol. 2022. PMID: 35314495 No abstract available.
Regenerating myelin.
Scolding N. Scolding N. Brain. 2001 Nov;124(Pt 11):2129-30. doi: 10.1093/brain/124.11.2129. Brain. 2001. PMID: 11673315 No abstract available.
Neurolupus.
Joseph FG, Scolding NJ. Joseph FG, et al. Among authors: scolding nj. Pract Neurol. 2010 Feb;10(1):4-15. doi: 10.1136/jnnp.2009.200071. Pract Neurol. 2010. PMID: 20130291 Review.
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs.
Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TW, Isenberg D, Kallenberg C, Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M, Tincani A, van Buchem MA, van Vollenhoven R, Ward M, Gordon C, Boumpas DT. Bertsias GK, et al. Among authors: scolding n. Ann Rheum Dis. 2010 Dec;69(12):2074-82. doi: 10.1136/ard.2010.130476. Epub 2010 Aug 19. Ann Rheum Dis. 2010. PMID: 20724309
Inflammatory/post-infectious encephalomyelitis.
Bennetto L, Scolding N. Bennetto L, et al. Among authors: scolding n. J Neurol Neurosurg Psychiatry. 2004 Mar;75 Suppl 1(Suppl 1):i22-8. doi: 10.1136/jnnp.2003.034256. J Neurol Neurosurg Psychiatry. 2004. PMID: 14978147 Free PMC article. Review. No abstract available.
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.
Brown JWL, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A, Girard M, Duquette P, Trojano M, Lugaresi A, Bergamaschi R, Grammond P, Alroughani R, Hupperts R, McCombe P, Van Pesch V, Sola P, Ferraro D, Grand'Maison F, Terzi M, Lechner-Scott J, Flechter S, Slee M, Shaygannejad V, Pucci E, Granella F, Jokubaitis V, Willis M, Rice C, Scolding N, Wilkins A, Pearson OR, Ziemssen T, Hutchinson M, Harding K, Jones J, McGuigan C, Butzkueven H, Kalincik T, Robertson N; MSBase Study Group. Brown JWL, et al. Among authors: scolding n. JAMA. 2019 Jan 15;321(2):175-187. doi: 10.1001/jama.2018.20588. JAMA. 2019. PMID: 30644981 Free PMC article.
IgG4-related disease in the nervous system.
Yang L, Smith RJP, Scolding NJ, Rice CM. Yang L, et al. Among authors: scolding nj. Pract Neurol. 2024 Sep 12:practneurol-2020-002863. doi: 10.1136/pn-2020-002863. Online ahead of print. Pract Neurol. 2024. PMID: 39266448 Review.
Subacute neurological syndromes.
Scolding N, Fuller G. Scolding N, et al. Clin Med (Lond). 2004 Mar-Apr;4(2):122-4. doi: 10.7861/clinmedicine.4-2-122. Clin Med (Lond). 2004. PMID: 15139728 Free PMC article. Review.
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial.
Brittain G, Petrie J, Duffy KEM, Glover R, Hullock K, Papaioannou D, Roldan E, Beecher C, Bursnall M, Ciccarelli O, Coles AJ, Cooper C, Giovannoni G, Gabriel I, Kazmi M, Kyriakou C, Nicholas R, Paling D, Peniket A, Scolding N, Silber E, de Silva T, Venneri A, Walters SJ, Young C, Muraro PA, Sharrack B, Snowden JA; StarMS trial team. Brittain G, et al. Among authors: scolding n. BMJ Open. 2024 Feb 5;14(2):e083582. doi: 10.1136/bmjopen-2023-083582. BMJ Open. 2024. PMID: 38316583 Free PMC article.
239 results